| Generic Name | Composition | Brand Name |
| Paclitaxel Injection IP 6mg/ml, 30mg/5ml | Each ml Contains: | Pacten 30 |
| Liquid Injection | Paclitaxel IP……………………………6mg |
| | Polyoxyl 35 Castor Oil IP……………..527mg |
| | Dehydrated Alcohol IP……………49.7% v/v |
| Paclitaxel Injection IP 6mg/ml, 100mg/16.7ml | Each ml Contains: | |
| Liquid Injection | Paclitaxel IP……………………………6mg | Pacten 100 |
| | Polyoxyl 35 Castor Oil IP……………..527mg | |
| | Dehydrated Alcohol IP……………49.7% v/v | |
| Paclitaxel Injection IP 6mg/ml, 102mg/17ml | Each ml Contains: | Pacten 102 |
| Liquid Injection | Paclitaxel IP……………………………6mg |
| | Polyoxyl 35 Castor Oil IP……………..527mg |
| | Dehydrated Alcohol IP……………49.7% v/v |
| Paclitaxel Injection IP 6mg/ml, 260mg/43.4ml | Each ml Contains: | Pacten 260 |
| Liquid Injection | Paclitaxel IP……………………………6mg |
| | Polyoxyl 35 Castor Oil IP………………..527mg |
| | Dehydrated Alcohol IP………………49.7% v/v |
| Paclitaxel Injection IP 6mg/ml, 300mg/50ml | Each ml Contains: | Pacten 300 |
| Liquid Injection | Paclitaxel IP……………………………6mg |
| | Polyoxyl 35 Castor Oil IP……………..527mg |
| | Dehydrated Alcohol IP……………49.7% v/v |
| Irinotecan hydrochloride injection IP 20 mg/ml (100mg/5 ml) Liquid Injection | Each ml Contains: | Irinoten 100 |
| Irinotecan Hydrochloride Trihydrate IP…20mg |
| Sorbitol IP……………………………….45mg |
| Lactic acid IP…………………………….0.9mg |
| Water For Injection IP……………………..q.s. |
| Irinotecan hydrochloride injection IP 20 mg/ml (40mg/2 ml) | Each ml Contains: | Irinoten 40 |
| Liquid Injection | Irinotecan Hydrochloride Trihydrate IP…20mg |
| | Sorbitol IP……………………………….45mg |
| | Lactic acid IP…………………………….0.9mg |
| | Water For Injection IP……………………..q.s. |
| Epirubicin Hydrochloride Injection 2mg/ml | Each ml contains | Epirten 10 |
| Doxorubicin Hydrochloride Injection IP 2 mg/ml | Each ml contains | Doxten 10 |
| (10 mg in 5 ml) | Doxorubicin Hydrochloride IP……………2mg |
| Liquid Injection | Sodium Chloride IP………………………9mg |
| | Water for Injections IP……………………q.s. |
| Doxorubicin Hydrochloride Injection IP 2 mg/ml, | Each ml contains | Doxten 50 |
| (50 mg/25 ml) | Doxorubicin Hydrochloride IP……………2mg |
| Liquid Injection | Sodium Chloride IP………………………9mg |
| | Water for Injections IP……………………q.s. |
| Carboplatin Injection IP 10 mg/ml (150mg/15 ml) | Each ml Contains: | Carboten 150 |
| Liquid Injection | Carboplatin IP………………………10mg |
| | Water For Injection IP……………………..q.s. |
| Carboplatin Injection IP 10 mg/ml (450mg/45ml) | Each ml Contains: | Carboten 450 |
| Liquid Injection | Carboplatin IP………………………10mg |
| | Water For Injection IP……………………..q.s. |
| Cisplatin Injection IP 0.5mg/ml, (10mg/20ml) | Each ml Contains: | Cisten 10 |
| Liquid Injection | Cisplatin IP…………………………….0.5mg |
| | Sodium Chloride……………………….9mg |
| | Water For Injection IP……………………..q.s. |
| Cisplatin Injection BP 1mg/ml, (10mg/10ml) | Each ml Contains: | |
| Liquid Injection | Cisplatin IP…………………………….1mg | Cisten B10 |
| | Sodium Chloride……………………….9mg | |
| | Water For Injection IP……………………..q.s. | |
| Oxaliplatin Injection IP 5mg/ml, (50mg/10ml) | Each ml Contains: | Oxaten 50 |
| Liquid Injection | Oxaliplatin IP…………………………….5mg |
| | Water For Injection IP……………………..q.s. |
| Oxaliplatin Injection IP 5mg/ml, (100mg/20ml) | Each ml Contains: | Oxaten 100 |
| Liquid Injection | Oxaliplatin IP…………………………….5mg |
| | Water For Injection IP……………………..q.s. |
| Methotrexate Injection IP 25mg/ml (50mg/2ml) | Each ml Contains: | Methoten 50 |
| Liquid Injection | Methotrexate IP………………………25mg |
| | Sodium Chloride………………………. 4.9 mg |
| | Water For Injection IP……………………..q.s. |
| Methotrexate Injection IP 25mg/ml (500mg/20ml) | Each ml Contains: | Methoten 500 |
| Liquid Injection | Methotrexate IP………………………25mg |
| | Sodium Chloride………………………. 4.9 mg |
| | Water For Injection IP……………………..q.s. |
| Methotrexate Injection IP 25mg/ml (1000mg/40ml) | Each ml Contains: | Methoten 1000 |
| Liquid Injection | Methotrexate IP………………………25mg |
| | Sodium Chloride………………………. 4.9 mg |
| | Water For Injection IP……………………..q.s. |
| Cytarabine Injection IP 20mg/ml (500mg/25ml) | Each ml Contains: | Cytraten 500 |
| Liquid Injection | Cytarabine IP…………………………….20mg |
| | Water For Injection IP……………………..q.s. |
| Etoposide Injection IP 20mg/ml (100mg/5ml) | Each ml Contains: | Etopoten 100 |
| Liquid Injection | Etoposide IP………………………20mg |
| | Absolute Alcohol IP……………..30.5%v/v |
| | Non aqueous Vehicle …………………….q.s. |
| | |
| Docetaxel Injection IP 20mg/ml (80mg/4ml) | Each ml Contains: | Doceten 80 |
| Liquid Injection | Docetaxel IP………………………………20mg |
| | Polysorbate 80 IP……………..……….520mg |
| | Dehydrated alcohol IP……………..q.s. to 1ml |
| | |
| Docetaxel Injection IP 20mg/ml (120mg/6ml) | Each ml Contains: | Doceten 120 |
| Liquid Injection | Docetaxel IP………………………………20mg |
| | Polysorbate 80 IP………………..…….520mg |
| | Dehydrated alcohol IP……………..q.s. to 1ml |
| Pemetrexed Injection IP 100mg | Each vial contains | Pemeten 100-L |
| Lyophilized Powder | Pemetrexed Disodium Heptahydrate IP Equivalent to Pemetrexed……………….100mg |
| | |
| | Excipients ………………… q.s |
| | |
| Pemetrexed Injection IP 500mg | Each vial contains | Pemeten 500-L |
| Lyophilized Powder | Pemetrexed Disodium Heptahydrate IP Equivalent to Pemetrexed……………….500mg |
| | |
| | Excipients ………………….q.s |
| Zoledronic Acid Injection 4mg | Each vial contains | Zoleten 4-L |
| Lyophilized Powder | Zoledronic Acid Monohydrate IP Eq. to Zoledronic Acid (Anhydrous)……..4mg |
| | |
| | Mannitol IP……………………………..220mg |
| | Sodium Citrate IP………………………..24mg |
| Dacarbazine for Injection 100 mg | Each vial contains | Dacarbaten 100-L |
| Lyophilized Powder | Dacarbazine IP……………..………..100mg |
| | Excipients………………………………..q.s. |
| | |
| Dacarbazine for Injection 200 mg | Each vial contains | Dacarbaten 200-L |
| Lyophilized Powder | Dacarbazine IP…………………..…..200mg |
| | Excipients………………………………..q.s. |
| Dacarbazine for Injection 500 mg | Each vial contains | Dacarbaten 500-L |
| Lyophilized Powder | Dacarbazine IP……………..………..500mg |
| | Excipients………………………………..q.s. |
| Bortezomib Injection 2mg | Each vial contains | Zomiten 2-L |
| Lyophilized Powder | Bortezomib IP…………………..………..2mg |
| | Excipients………………………………..q.s. |
| Bortezomib Injection 3.5 mg | Each vial contains | Zomiten 3.5-L |
| Lyophilized Powder | Bortezomib IP…………………..……..3.5mg |
| | Excipients………………………………..q.s. |
| Gemcitabine Injection IP 200mg | Each Vial Contains: | Gemciten 200-L |
| Lyophilized | Gemcitabine Hydrochloride IP Eq. to Gemcitabine………………………200 mg. |
| | |
| | Excipients………………………………..q.s. |
| Gemcitabine Injection IP 1gm | Each Vial Contains: | Gemciten 1-L |
| Lyophilized | Gemcitabine Hydrochloride IP Eq. to Gemcitabine………………………1 gm. |
| | |
| | Excipients………………………………..q.s. |
| Gemcitabine Injection IP 1.4gm | Each Vial Contains: | Gemciten 1.4-L |
| Lyophilized | Gemcitabine Hydrochloride IP Eq. to Gemcitabine………………………1.4 gm. |
| | |
| | Excipients………………………………..q.s. |